Eagle Health Investments L.P. 13F annual report
Eagle Health Investments L.P. is an investment fund managing more than $560 billion ran by Gary Stern. There are currently 25 companies in Mr. Stern’s portfolio. The largest investments include United Therapeutics Corp and Natera Inc, together worth $105 billion.
$560 billion Assets Under Management (AUM)
As of 6th August 2024, Eagle Health Investments L.P.’s top holding is 167,499 shares of United Therapeutics Corp currently worth over $53.4 billion and making up 9.5% of the portfolio value.
Relative to the number of outstanding shares of United Therapeutics Corp, Eagle Health Investments L.P. owns more than approximately 0.1% of the company.
In addition, the fund holds 474,114 shares of Natera Inc worth $51.3 billion, whose value grew 68.5% in the past six months.
The third-largest holding is Icon Plc worth $46.9 billion and the next is Unitedhealth Inc worth $44.3 billion, with 86,900 shares owned.
Currently, Eagle Health Investments L.P.'s portfolio is worth at least $560 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Eagle Health Investments L.P.
The Eagle Health Investments L.P. office and employees reside in Greenwich, Connecticut. According to the last 13-F report filed with the SEC, Gary Stern serves as the FOUNDER AND CHIEF INVESTMENT OFFICER at Eagle Health Investments L.P..
Recent trades
In the most recent 13F filing, Eagle Health Investments L.P. revealed that it had opened a new position in
Unitedhealth Inc and bought 86,900 shares worth $44.3 billion.
This means they effectively own approximately 0.1% of the company.
Unitedhealth Inc makes up
9.8%
of the fund's Health Care sector allocation and has decreased its share price by approximately 0.1% in the past year.
The investment fund also strengthened its position in Argenx Se by buying
4,300 additional shares.
This makes their stake in Argenx Se total 88,890 shares worth $38.2 billion.
On the other hand, there are companies that Eagle Health Investments L.P. is getting rid of from its portfolio.
Eagle Health Investments L.P. closed its position in Danaher on 13th August 2024.
It sold the previously owned 113,685 shares for $28.4 billion.
Gary Stern also disclosed a decreased stake in United Therapeutics Corp by approximately 0.1%.
This leaves the value of the investment at $53.4 billion and 167,499 shares.
One of the average hedge funds
The two most similar investment funds to Eagle Health Investments L.P. are Arete Wealth Advisors and Meridian Wealth Advisors. They manage $560 billion and $559 billion respectively.
Gary Stern investment strategy
Eagle Health Investments L.P.’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 80.8% of
the total portfolio value.
The fund focuses on investments in the United States as
64.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
36% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $46.5 billion.
The complete list of Eagle Health Investments L.P. trades based on 13F SEC filings
These positions were updated on August 13th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| United Therapeutics Corp |
6.69%
167,499
|
$53,356,806,000 | 9.54% |
| Natera Inc |
25.07%
474,114
|
$51,341,805,000 | 9.18% |
| Icon Plc |
No change
149,590
|
$46,891,977,000 | 8.38% |
| Unitedhealth Group Inc |
Opened
86,900
|
$44,254,694,000 | 7.91% |
| Argenx Se |
5.08%
88,890
|
$38,226,256,000 | 6.83% |
| Insmed Inc |
Opened
513,700
|
$34,417,900,000 | 6.15% |
| Illumina Inc |
No change
318,754
|
$33,271,543,000 | 5.95% |
| Dexcom Inc |
3.23%
275,718
|
$31,260,907,000 | 5.59% |
| Danaher Corp. |
Closed
113,685
|
$28,389,418,000 | |
| IQVIA Holdings Inc |
No change
121,895
|
$25,773,479,000 | 4.61% |
| Exact Sciences Corp. |
349.75%
544,200
|
$22,992,450,000 | 4.11% |
| Ultragenyx Pharmaceutical In |
75.01%
524,500
|
$21,556,950,000 | 3.85% |
| TransMedics Group, Inc. |
52.32%
132,861
|
$20,011,524,000 | 3.58% |
| Biomarin Pharmaceutical Inc. |
Opened
231,800
|
$19,084,094,000 | 3.41% |
| Alnylam Pharmaceuticals Inc |
57.70%
76,256
|
$18,530,208,000 | 3.31% |
| Inspire Med Sys Inc |
11.78%
136,603
|
$18,281,579,000 | 3.27% |
| Guardant Health Inc |
14.15%
626,909
|
$18,105,132,000 | 3.24% |
| Procept Biorobotics Corp |
23.76%
257,089
|
$15,705,567,000 | 2.81% |
| Agios Pharmaceuticals Inc |
No change
330,830
|
$14,265,390,000 | 2.55% |
| Sarepta Therapeutics Inc |
Closed
103,256
|
$13,367,522,000 | |
| Intuitive Surgical Inc |
20.51%
28,290
|
$12,584,807,000 | 2.25% |
| Fusion Pharmaceuticals Inc. |
Closed
579,769
|
$12,360,675,000 | |
| 4d Molecular Therapeutics In |
No change
462,911
|
$9,716,502,000 | 1.74% |
| Pacific Biosciences Calif In |
Closed
2,167,021
|
$8,126,329,000 | |
| 10x Genomics, Inc. |
Closed
135,059
|
$5,068,764,000 | |
| Lantheus Holdings Inc |
No change
43,200
|
$3,468,528,000 | 0.62% |
| Viking Therapeutics Inc |
No change
45,000
|
$2,385,450,000 | 0.43% |
| Werewolf Therapeutics Inc |
No change
700,000
|
$1,708,000,000 | 0.31% |
| Immunocore Hldgs Plc |
No change
46,300
|
$1,569,107,000 | 0.28% |
| Grail Inc |
Opened
53,124
|
$816,516,000 | 0.15% |
| No transactions found | |||
| Showing first 500 out of 30 holdings | |||
Hedge funds similar to Eagle Health Investments L.P.
- Yelin Lapidot Management
- Red Door Wealth Management
- Chatham Capital Group, Inc
- Solel Partners L.P.
- New England Private Wealth Advisors
- Rbo & Co
- Arete Wealth Advisors
- Meridian Wealth Advisors
- Ironwood Investment Counsel
- Viking Fund Management
- Legacy Advisors
- Core Alternative Capital
- Strategic Point Investment Advisors
- Cva Family Office